FDA Proposes to Strengthen Label Warning for Xolair The boxed
FDA Proposes to Strengthen Label Warning for Xolair
The boxed warning emphasizes that Xolair, used to treat patients with asthma related to allergies, may cause anaphylaxis.
« Cardinal Health 303, Inc. Signs Consent Decree with FDA, Agrees | Main | FDA Approvals - Merck is on the mend (CNN Money) In the dark »